Glofitamab
(Anti-human CD20 mAb, human IgG1-Kappa; RG-6026)
Catalog No.: PC-Ab1034Not For Human Use, Lab Use Only.
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells a CD20/CD3 antibody (comprising two Fab regions for CD20 and one Fab region for CD3). Glofitamab redirects T cells to engage and eliminate malignant B cells..
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells a CD20/CD3 antibody (comprising two Fab regions for CD20 and one Fab region for CD3). Glofitamab redirects T cells to engage and eliminate malignant B cells.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
